المؤلفون: Murphy B; Immunology, Microenvironment & Metastasis Program, Ellen and Ronald Caplan Cancer Center, The Wistar Institute, Philadelphia, PA, USA., Miyamoto T; Immunology, Microenvironment & Metastasis Program, Ellen and Ronald Caplan Cancer Center, The Wistar Institute, Philadelphia, PA, USA., Manning BS; Immunology, Microenvironment & Metastasis Program, Ellen and Ronald Caplan Cancer Center, The Wistar Institute, Philadelphia, PA, USA., Mirji G; Immunology, Microenvironment & Metastasis Program, Ellen and Ronald Caplan Cancer Center, The Wistar Institute, Philadelphia, PA, USA., Ugolini A; Immunology, Microenvironment & Metastasis Program, Ellen and Ronald Caplan Cancer Center, The Wistar Institute, Philadelphia, PA, USA., Kannan T; Gene Expression & Regulation Program, Ellen and Ronald Caplan Cancer Center, The Wistar Institute, Philadelphia, PA, USA., Hamada K; Department of Gynecology and Obstetrics, Kyoto University, Japan., Zhu YP; Medical College of Georgia, Augusta University, Augusta, GA, USA., Claiborne DT; Immunology, Microenvironment & Metastasis Program, Ellen and Ronald Caplan Cancer Center, The Wistar Institute, Philadelphia, PA, USA., Huang L; Department of Microbiology and Immunology, University of Arkansas for Medical Sciences, Little Rock, AR, USA., Zhang R; Immunology, Microenvironment & Metastasis Program, Ellen and Ronald Caplan Cancer Center, The Wistar Institute, Philadelphia, PA, USA.; Department of Experimental Therapeutics, MD Anderson Cancer Center, Houston, TX, USA., Nefedova Y; Immunology, Microenvironment & Metastasis Program, Ellen and Ronald Caplan Cancer Center, The Wistar Institute, Philadelphia, PA, USA., Kossenkov A; Gene Expression & Regulation Program, Ellen and Ronald Caplan Cancer Center, The Wistar Institute, Philadelphia, PA, USA., Veglia F; Immunology, Microenvironment & Metastasis Program, Ellen and Ronald Caplan Cancer Center, The Wistar Institute, Philadelphia, PA, USA., Shinde R; Immunology, Microenvironment & Metastasis Program, Ellen and Ronald Caplan Cancer Center, The Wistar Institute, Philadelphia, PA, USA., Zhang N; Immunology, Microenvironment & Metastasis Program, Ellen and Ronald Caplan Cancer Center, The Wistar Institute, Philadelphia, PA, USA.

المصدر: BioRxiv : the preprint server for biology [bioRxiv] 2024 Jun 29. Date of Electronic Publication: 2024 Jun 29.

نوع المنشور: Journal Article; Preprint

بيانات الدورية: Country of Publication: United States NLM ID: 101680187 Publication Model: Electronic Cited Medium: Internet ISSN: 2692-8205 (Electronic) Linking ISSN: 26928205 NLM ISO Abbreviation: bioRxiv Subsets: PubMed not MEDLINE

المؤلفون: Nie H; Department of Experimental Therapeutics, University of Texas MD Anderson Cancer Center, Houston, TX, 77054, USA., Saini P; Vaccine and Immunotherapy Center, The Wistar Institute, Philadelphia, PA, 19104, USA., Miyamoto T; Immunology, Microenvironment and Metastasis Program, The Wistar Institute, Philadelphia, PA, 19104, USA., Liao L; Department of Experimental Therapeutics, University of Texas MD Anderson Cancer Center, Houston, TX, 77054, USA., Zielinski RJ; Department of Experimental Therapeutics, University of Texas MD Anderson Cancer Center, Houston, TX, 77054, USA., Liu H; Immunology, Microenvironment and Metastasis Program, The Wistar Institute, Philadelphia, PA, 19104, USA., Zhou W; Immunology, Microenvironment and Metastasis Program, The Wistar Institute, Philadelphia, PA, 19104, USA., Wang C; Department of Experimental Therapeutics, University of Texas MD Anderson Cancer Center, Houston, TX, 77054, USA., Murphy B; Immunology, Microenvironment and Metastasis Program, The Wistar Institute, Philadelphia, PA, 19104, USA., Towers M; Department of Experimental Therapeutics, University of Texas MD Anderson Cancer Center, Houston, TX, 77054, USA., Yang T; Immunology, Microenvironment and Metastasis Program, The Wistar Institute, Philadelphia, PA, 19104, USA., Qi Y; Department of Bioinformatics & Computational Biology, University of Texas MD Anderson Cancer Center, Houston, TX, 77054, USA., Kannan T; Bioinformatics Facility, The Wistar Institute, Philadelphia, PA, 19104, USA., Kossenkov A; Gene Expression and Regulation Program, The Wistar Institute, Philadelphia, PA, 19104, USA., Tateno H; Cellular and Molecular Biotechnology Research Institute, National Institute of Advanced Industrial Science and Technology (AIST), Tsukuba, Ibaraki, 305-8566, Japan., Claiborne DT; Immunology, Microenvironment and Metastasis Program, The Wistar Institute, Philadelphia, PA, 19104, USA., Zhang N; Immunology, Microenvironment and Metastasis Program, The Wistar Institute, Philadelphia, PA, 19104, USA., Abdel-Mohsen M; Vaccine and Immunotherapy Center, The Wistar Institute, Philadelphia, PA, 19104, USA. mmohsen@wistar.org., Zhang R; Department of Experimental Therapeutics, University of Texas MD Anderson Cancer Center, Houston, TX, 77054, USA. rzhang11@mdanderson.org.; Immunology, Microenvironment and Metastasis Program, The Wistar Institute, Philadelphia, PA, 19104, USA. rzhang11@mdanderson.org.

المصدر: Nature communications [Nat Commun] 2024 Apr 02; Vol. 15 (1), pp. 2853. Date of Electronic Publication: 2024 Apr 02.

نوع المنشور: Journal Article

بيانات الدورية: Publisher: Nature Pub. Group Country of Publication: England NLM ID: 101528555 Publication Model: Electronic Cited Medium: Internet ISSN: 2041-1723 (Electronic) Linking ISSN: 20411723 NLM ISO Abbreviation: Nat Commun Subsets: MEDLINE

مواضيع طبية MeSH: BRCA1 Protein*/metabolism , Ovarian Neoplasms*/pathology, Humans ; Female ; Animals ; Mice ; Immune Checkpoint Inhibitors/therapeutic use ; CD8-Positive T-Lymphocytes/metabolism ; Glycosylation ; BRCA2 Protein/metabolism ; Carcinoma, Ovarian Epithelial/drug therapy ; B7-H1 Antigen/metabolism

المؤلفون: Joshi VR; Ragon Institute of Mass General, MIT and Harvard, Cambridge, Massachusetts, USA.; Department of Virology, Harvard Medical School, Boston, Massachusetts, USA.; Department of Virus Immunology, Leibniz Institute of Virology, Hamburg, Germany., Claiborne DT; Ragon Institute of Mass General, MIT and Harvard, Cambridge, Massachusetts, USA., Pack ML; Ragon Institute of Mass General, MIT and Harvard, Cambridge, Massachusetts, USA., Power KA; Ragon Institute of Mass General, MIT and Harvard, Cambridge, Massachusetts, USA., Newman RM; Ragon Institute of Mass General, MIT and Harvard, Cambridge, Massachusetts, USA., Batorsky R; Ragon Institute of Mass General, MIT and Harvard, Cambridge, Massachusetts, USA., Bean DJ; Ragon Institute of Mass General, MIT and Harvard, Cambridge, Massachusetts, USA., Goroff MS; Ragon Institute of Mass General, MIT and Harvard, Cambridge, Massachusetts, USA., Lingwood D; Ragon Institute of Mass General, MIT and Harvard, Cambridge, Massachusetts, USA., Seaman MS; Center for Virology and Vaccine Research, Beth Israel Deaconess Medical Center, Boston, Massachusetts, USA., Rosenberg E; Department of Medicine, Massachusetts General Hospital, Boston, Massachusetts, USA.; Department of Pathology, Massachusetts General Hospital, Boston, Massachusetts, USA., Allen TM; Ragon Institute of Mass General, MIT and Harvard, Cambridge, Massachusetts, USA.; Department of Medicine, Massachusetts General Hospital, Boston, Massachusetts, USA.

المصدر: Journal of virology [J Virol] 2024 Mar 19; Vol. 98 (3), pp. e0172023. Date of Electronic Publication: 2024 Feb 27.

نوع المنشور: Journal Article

بيانات الدورية: Publisher: American Society For Microbiology Country of Publication: United States NLM ID: 0113724 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1098-5514 (Electronic) Linking ISSN: 0022538X NLM ISO Abbreviation: J Virol Subsets: MEDLINE

مواضيع طبية MeSH: Broadly Neutralizing Antibodies*/immunology , HIV Infections*, Humans ; Amino Acids ; CD4 Antigens/genetics ; env Gene Products, Human Immunodeficiency Virus/genetics ; Epitopes ; HIV Antibodies ; HIV Antigens ; HIV Envelope Protein gp120/genetics ; HIV Seropositivity ; HIV-1/genetics ; AIDS Vaccines/immunology

المؤلفون: Miller KD; The Wistar Institute of Anatomy and Biology, Molecular and Cellular Oncogenesis Program, Philadelphia, PA, USA., O'Connor S; The Wistar Institute of Anatomy and Biology, Molecular and Cellular Oncogenesis Program, Philadelphia, PA, USA., Pniewski KA; The Wistar Institute of Anatomy and Biology, Molecular and Cellular Oncogenesis Program, Philadelphia, PA, USA., Kannan T; The Wistar Institute of Anatomy and Biology, Molecular and Cellular Oncogenesis Program, Philadelphia, PA, USA., Acosta R; The Wistar Institute of Anatomy and Biology, Vaccine and Immunotherapy Center, Philadelphia, PA, USA., Mirji G; The Wistar Institute of Anatomy and Biology, Immunology, Microenvironment & Metastasis Program, Philadelphia, PA, USA., Papp S; The Wistar Institute of Anatomy and Biology, Molecular and Cellular Oncogenesis Program, Philadelphia, PA, USA., Hulse M; The Wistar Institute of Anatomy and Biology, Molecular and Cellular Oncogenesis Program, Philadelphia, PA, USA., Mukha D; The Wistar Institute of Anatomy and Biology, Molecular and Cellular Oncogenesis Program, Philadelphia, PA, USA., Hlavaty SI; The Wistar Institute of Anatomy and Biology, Molecular and Cellular Oncogenesis Program, Philadelphia, PA, USA., Salcido KN; The Wistar Institute of Anatomy and Biology, Molecular and Cellular Oncogenesis Program, Philadelphia, PA, USA., Bertolazzi F; The Wistar Institute of Anatomy and Biology, Molecular and Cellular Oncogenesis Program, Philadelphia, PA, USA.; Cellular and Molecular Biology Program, Department of Pharmacy and Biotechnology, University of Bologna, Bologna, Italy., Srikanth YVV; The Wistar Institute of Anatomy and Biology, Molecular and Cellular Oncogenesis Program, Philadelphia, PA, USA., Zhao S; Department of Cancer Biology, University of Pennsylvania, Philadelphia, PA, USA., Wellen KE; Department of Cancer Biology, University of Pennsylvania, Philadelphia, PA, USA.; Abramson Family Cancer Research Institute, University of Pennsylvania, Philadelphia, PA, USA., Shinde RS; The Wistar Institute of Anatomy and Biology, Immunology, Microenvironment & Metastasis Program, Philadelphia, PA, USA., Claiborne DT; The Wistar Institute of Anatomy and Biology, Vaccine and Immunotherapy Center, Philadelphia, PA, USA., Kossenkov A; The Wistar Institute of Anatomy and Biology, Molecular and Cellular Oncogenesis Program, Philadelphia, PA, USA., Salvino JM; The Wistar Institute of Anatomy and Biology, Molecular and Cellular Oncogenesis Program, Philadelphia, PA, USA., Schug ZT; The Wistar Institute of Anatomy and Biology, Molecular and Cellular Oncogenesis Program, Philadelphia, PA, USA. zschug@wistar.org.

المصدر: Nature cancer [Nat Cancer] 2023 Oct; Vol. 4 (10), pp. 1491-1507. Date of Electronic Publication: 2023 Sep 18.

نوع المنشور: Journal Article

بيانات الدورية: Publisher: Nature Publishing Group Country of Publication: England NLM ID: 101761119 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 2662-1347 (Electronic) Linking ISSN: 26621347 NLM ISO Abbreviation: Nat Cancer Subsets: MEDLINE

مواضيع طبية MeSH: Breast Neoplasms*/drug therapy, Humans ; Female ; Acetyl Coenzyme A/metabolism ; Cell Line, Tumor ; Acetates/pharmacology ; Acetates/therapeutic use ; Acetates/metabolism ; T-Lymphocytes/metabolism ; Immunologic Factors ; Tumor Microenvironment

المؤلفون: Stieg DC; Program in Molecular and Cellular Oncogenesis, The Wistar Institute, Philadelphia, Pennsylvania., Parris JLD; Program in Molecular and Cellular Oncogenesis, The Wistar Institute, Philadelphia, Pennsylvania., Yang THL; Program in Immunology, Microenvironment, and Metastasis, The Wistar Institute, Philadelphia, Pennsylvania., Mirji G; Program in Immunology, Microenvironment, and Metastasis, The Wistar Institute, Philadelphia, Pennsylvania., Reiser SK; Program in Immunology, Microenvironment, and Metastasis, The Wistar Institute, Philadelphia, Pennsylvania., Murali N; Program in Molecular and Cellular Oncogenesis, The Wistar Institute, Philadelphia, Pennsylvania., Werts M; Program in Immunology, Microenvironment, and Metastasis, The Wistar Institute, Philadelphia, Pennsylvania., Barnoud T; Department of Biochemistry and Molecular Biology, Medical University of South Carolina, Charleston, South Carolina., Lu DY; Program in Molecular and Cellular Oncogenesis, The Wistar Institute, Philadelphia, Pennsylvania., Shinde R; Program in Immunology, Microenvironment, and Metastasis, The Wistar Institute, Philadelphia, Pennsylvania., Murphy ME; Program in Molecular and Cellular Oncogenesis, The Wistar Institute, Philadelphia, Pennsylvania., Claiborne DT; Program in Immunology, Microenvironment, and Metastasis, The Wistar Institute, Philadelphia, Pennsylvania.; Vaccine and Immunotherapy Center, The Wistar Institute, Philadelphia, Pennsylvania.

المصدر: Cancer research communications [Cancer Res Commun] 2023 Jul 11; Vol. 3 (7), pp. 1200-1211. Date of Electronic Publication: 2023 Jul 11 (Print Publication: 2023).

نوع المنشور: Journal Article; Research Support, N.I.H., Extramural

بيانات الدورية: Publisher: American Association for Cancer Research Country of Publication: United States NLM ID: 9918281580506676 Publication Model: eCollection Cited Medium: Internet ISSN: 2767-9764 (Electronic) Linking ISSN: 27679764 NLM ISO Abbreviation: Cancer Res Commun Subsets: MEDLINE

مواضيع طبية MeSH: Tumor Suppressor Protein p53*/genetics , Li-Fraumeni Syndrome*/genetics, Humans ; Mice ; Animals ; Immune Checkpoint Inhibitors ; Genes, p53 ; Germ-Line Mutation ; Tumor Microenvironment/genetics

المؤلفون: Indeglia A; Program in Molecular and Cellular Oncogenesis, The Wistar Institute, Philadelphia, Pennsylvania.; Graduate Group in Biochemistry and Molecular Biophysics, Perelman School of Medicine, University of Pennsylvania, Philadelphia, Pennsylvania., Leung JC; Program in Molecular and Cellular Oncogenesis, The Wistar Institute, Philadelphia, Pennsylvania., Miller SA; Program in Molecular Therapeutics, Fox Chase Cancer Center, Philadelphia, Pennsylvania., Leu JI; Department of Genetics, Perelman School of Medicine, University of Pennsylvania, Philadelphia, Pennsylvania., Dougherty JF; Program in Molecular and Cellular Oncogenesis, The Wistar Institute, Philadelphia, Pennsylvania., Clarke NL; Program in Molecular and Cellular Oncogenesis, The Wistar Institute, Philadelphia, Pennsylvania., Kirven NA; Program in Molecular and Cellular Oncogenesis, The Wistar Institute, Philadelphia, Pennsylvania., Shao C; Program in Molecular and Cellular Oncogenesis, The Wistar Institute, Philadelphia, Pennsylvania., Ke L; Program in Molecular Therapeutics, Fox Chase Cancer Center, Philadelphia, Pennsylvania., Lovell S; Del Shankel Structural Biology Center, The University of Kansas, Lawrence, Kansas., Barnoud T; Program in Molecular and Cellular Oncogenesis, The Wistar Institute, Philadelphia, Pennsylvania., Lu DY; Program in Molecular and Cellular Oncogenesis, The Wistar Institute, Philadelphia, Pennsylvania., Lin C; Program in Immunology, Microenvironment and Metastasis, The Wistar Institute, Philadelphia, Pennsylvania., Kannan T; Program in Gene Expression and Regulation, The Wistar Institute, Philadelphia, Pennsylvania., Battaile KP; NYX, New York Structural Biology Center, Upton, New York., Yang THL; Program in Immunology, Microenvironment and Metastasis, The Wistar Institute, Philadelphia, Pennsylvania., Batista Oliva I; Program in Molecular and Cellular Oncogenesis, The Wistar Institute, Philadelphia, Pennsylvania., Claiborne DT; Program in Immunology, Microenvironment and Metastasis, The Wistar Institute, Philadelphia, Pennsylvania., Vogel P; Department of Pathology, St. Jude Children's Research Hospital, Memphis, Tennessee., Liu L; Del Shankel Structural Biology Center, The University of Kansas, Lawrence, Kansas., Liu Q; Program in Molecular and Cellular Oncogenesis, The Wistar Institute, Philadelphia, Pennsylvania., Nefedova Y; Program in Immunology, Microenvironment and Metastasis, The Wistar Institute, Philadelphia, Pennsylvania., Cassel J; Program in Molecular and Cellular Oncogenesis, The Wistar Institute, Philadelphia, Pennsylvania., Auslander N; Program in Molecular and Cellular Oncogenesis, The Wistar Institute, Philadelphia, Pennsylvania., Kossenkov AV; Program in Gene Expression and Regulation, The Wistar Institute, Philadelphia, Pennsylvania., Karanicolas J; Program in Molecular Therapeutics, Fox Chase Cancer Center, Philadelphia, Pennsylvania., Murphy ME; Program in Molecular and Cellular Oncogenesis, The Wistar Institute, Philadelphia, Pennsylvania.

المصدر: Cancer discovery [Cancer Discov] 2023 Jul 07; Vol. 13 (7), pp. 1696-1719.

نوع المنشور: Journal Article; Research Support, N.I.H., Extramural; Research Support, U.S. Gov't, Non-P.H.S.; Research Support, Non-U.S. Gov't

بيانات الدورية: Publisher: American Association for Cancer Research Country of Publication: United States NLM ID: 101561693 Publication Model: Print Cited Medium: Internet ISSN: 2159-8290 (Electronic) Linking ISSN: 21598274 NLM ISO Abbreviation: Cancer Discov Subsets: MEDLINE

مواضيع طبية MeSH: Genes, p53* , Neoplasms*/genetics , Tumor Suppressor Protein p53*/metabolism, Animals ; Humans ; Mice ; African People/genetics

المؤلفون: Acosta R; Department of Microbiology, Perelman School of Medicine, University of Pennsylvania, 3451 Walnut Street, Philadelphia, PA 19104, United States.; Vaccine and Immunotherapy Center, The Wistar Institute, 3601 Spruce Street, Philadelphia, PA 19104, United States., Claiborne DT; Vaccine and Immunotherapy Center, The Wistar Institute, 3601 Spruce Street, Philadelphia, PA 19104, United States.

المصدر: Journal of leukocyte biology [J Leukoc Biol] 2023 May 02; Vol. 113 (5), pp. 415-417.

نوع المنشور: Editorial; Comment

بيانات الدورية: Publisher: Oxford University Press Country of Publication: England NLM ID: 8405628 Publication Model: Print Cited Medium: Internet ISSN: 1938-3673 (Electronic) Linking ISSN: 07415400 NLM ISO Abbreviation: J Leukoc Biol Subsets: MEDLINE

مواضيع طبية MeSH: Toll-Like Receptor 4*/immunology , HIV Infections*/immunology, Male ; Mice ; Humans ; Animals ; Mice, Inbred NOD ; Mice, SCID ; Immunity, Innate ; Immune System

المؤلفون: Zhou W; Immunology, Microenvironment and Metastasis Program, The Wistar Institute, Philadelphia, PA 19104, USA., Liu H; Immunology, Microenvironment and Metastasis Program, The Wistar Institute, Philadelphia, PA 19104, USA., Yuan Z; Immunology, Microenvironment and Metastasis Program, The Wistar Institute, Philadelphia, PA 19104, USA., Zundell J; Immunology, Microenvironment and Metastasis Program, The Wistar Institute, Philadelphia, PA 19104, USA., Towers M; Department of Experimental Therapeutics, University of Texas MD Anderson Cancer Center, Houston, TX 77054, USA., Lin J; Immunology, Microenvironment and Metastasis Program, The Wistar Institute, Philadelphia, PA 19104, USA., Lombardi S; Immunology, Microenvironment and Metastasis Program, The Wistar Institute, Philadelphia, PA 19104, USA; Department of Pharmacy and Biotechnology, University of Bologna, 40126, Bologna, Italy., Nie H; Immunology, Microenvironment and Metastasis Program, The Wistar Institute, Philadelphia, PA 19104, USA., Murphy B; Immunology, Microenvironment and Metastasis Program, The Wistar Institute, Philadelphia, PA 19104, USA., Yang T; Immunology, Microenvironment and Metastasis Program, The Wistar Institute, Philadelphia, PA 19104, USA., Wang C; Immunology, Microenvironment and Metastasis Program, The Wistar Institute, Philadelphia, PA 19104, USA., Liao L; Immunology, Microenvironment and Metastasis Program, The Wistar Institute, Philadelphia, PA 19104, USA., Goldman AR; Molecular and Cellular Oncogenesis Program, The Wistar Institute, Philadelphia, PA 19104, USA., Kannan T; Bioinformatics Facility, The Wistar Institute, Philadelphia, PA 19104, USA., Kossenkov AV; Gene Expression and Regulation Program, The Wistar Institute, Philadelphia, PA 19104, USA., Drapkin R; Department of Pathology and Laboratory Medicine, Perelman School of Medicine, University of Pennsylvania, Philadelphia, PA 19104, USA; Department of Obstetrics and Gynecology, Penn Ovarian Cancer Research Center, Perelman School of Medicine, University of Pennsylvania, Philadelphia, PA 19104, USA., Montaner LJ; Immunology, Microenvironment and Metastasis Program, The Wistar Institute, Philadelphia, PA 19104, USA., Claiborne DT; Immunology, Microenvironment and Metastasis Program, The Wistar Institute, Philadelphia, PA 19104, USA., Zhang N; Immunology, Microenvironment and Metastasis Program, The Wistar Institute, Philadelphia, PA 19104, USA., Wu S; Immunology, Microenvironment and Metastasis Program, The Wistar Institute, Philadelphia, PA 19104, USA., Zhang R; Immunology, Microenvironment and Metastasis Program, The Wistar Institute, Philadelphia, PA 19104, USA; Department of Experimental Therapeutics, University of Texas MD Anderson Cancer Center, Houston, TX 77054, USA. Electronic address: rzhang11@mdanderson.org.

المصدر: Cancer cell [Cancer Cell] 2023 Apr 10; Vol. 41 (4), pp. 740-756.e10. Date of Electronic Publication: 2023 Mar 23.

نوع المنشور: Journal Article; Research Support, Non-U.S. Gov't; Research Support, N.I.H., Extramural; Research Support, U.S. Gov't, Non-P.H.S.

بيانات الدورية: Publisher: Cell Press Country of Publication: United States NLM ID: 101130617 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1878-3686 (Electronic) Linking ISSN: 15356108 NLM ISO Abbreviation: Cancer Cell Subsets: MEDLINE

مواضيع طبية MeSH: Ovarian Neoplasms*/drug therapy , Ovarian Neoplasms*/genetics , Ovarian Neoplasms*/metabolism , Carcinoma*, Humans ; Female ; Mice ; Animals ; Mevalonic Acid ; Pyroptosis ; Nuclear Proteins/genetics ; Mutation ; DNA-Binding Proteins/genetics ; Transcription Factors/genetics

المؤلفون: Calvet-Mirabent M; Immunology Unit, Instituto de Investigación Sanitaria Princesa, Hospital Universitario de la Princesa, Madrid, Spain.; Medicine Department, Universidad Autónoma of Madrid, Madrid, Spain., Claiborne DT; Ragon Institute of MGH, MIT and Harvard, Cambridge, Massachusetts, USA., Deruaz M; Human Immune System Mouse Program, Massachusetts General Hospital, Boston, Massachusetts, USA.; Center for Immunology and Inflammatory Diseases, Massachusetts General Hospital, Boston, Massachusetts, USA., Tanno S; Ragon Institute of MGH, MIT and Harvard, Cambridge, Massachusetts, USA.; Human Immune System Mouse Program, Massachusetts General Hospital, Boston, Massachusetts, USA., Serra C; Infectious Diseases Department, Hospital Universitari Vall d'Hebron, Institut de Recerca (VHIR), Universitat Autònoma de Barcelona, Catalonia, Spain., Delgado-Arévalo C; Immunology Unit, Instituto de Investigación Sanitaria Princesa, Hospital Universitario de la Princesa, Madrid, Spain.; Medicine Department, Universidad Autónoma of Madrid, Madrid, Spain., Sánchez-Cerrillo I; Immunology Unit, Instituto de Investigación Sanitaria Princesa, Hospital Universitario de la Princesa, Madrid, Spain., de Los Santos I; Infectious Diseases Unit, Instituto de Investigación Sanitaria Princesa, Hospital Universitario de la Princesa, Madrid, Spain., Sanz J; Infectious Diseases Unit, Instituto de Investigación Sanitaria Princesa, Hospital Universitario de la Princesa, Madrid, Spain., García-Fraile L; Infectious Diseases Unit, Instituto de Investigación Sanitaria Princesa, Hospital Universitario de la Princesa, Madrid, Spain., Sánchez-Madrid F; Immunology Unit, Instituto de Investigación Sanitaria Princesa, Hospital Universitario de la Princesa, Madrid, Spain.; Medicine Department, Universidad Autónoma of Madrid, Madrid, Spain., Alfranca A; Immunology Unit, Instituto de Investigación Sanitaria Princesa, Hospital Universitario de la Princesa, Madrid, Spain., Muñoz-Fernández MÁ; Immunology Section, Instituto Investigación Sanitaria Gregorio Marañón (IiSGM), Hospital General Universitario Gregorio Marañón, Madrid, Spain., Allen TM; Ragon Institute of MGH, MIT and Harvard, Cambridge, Massachusetts, USA., Buzón MJ; Infectious Diseases Department, Hospital Universitari Vall d'Hebron, Institut de Recerca (VHIR), Universitat Autònoma de Barcelona, Catalonia, Spain., Balazs A; Ragon Institute of MGH, MIT and Harvard, Cambridge, Massachusetts, USA.; Human Immune System Mouse Program, Massachusetts General Hospital, Boston, Massachusetts, USA., Vrbanac V; Ragon Institute of MGH, MIT and Harvard, Cambridge, Massachusetts, USA.; Human Immune System Mouse Program, Massachusetts General Hospital, Boston, Massachusetts, USA., Martín-Gayo E; Immunology Unit, Instituto de Investigación Sanitaria Princesa, Hospital Universitario de la Princesa, Madrid, Spain.; Medicine Department, Universidad Autónoma of Madrid, Madrid, Spain.

المصدر: European journal of immunology [Eur J Immunol] 2022 Mar; Vol. 52 (3), pp. 447-461. Date of Electronic Publication: 2022 Jan 08.

نوع المنشور: Journal Article; Research Support, N.I.H., Extramural; Research Support, Non-U.S. Gov't

بيانات الدورية: Publisher: Wiley-VCH Country of Publication: Germany NLM ID: 1273201 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1521-4141 (Electronic) Linking ISSN: 00142980 NLM ISO Abbreviation: Eur J Immunol Subsets: MEDLINE

مواضيع طبية MeSH: AIDS Vaccines*/metabolism , HIV-1*, Adjuvants, Immunologic/pharmacology ; Animals ; CD4-Positive T-Lymphocytes ; CD8-Positive T-Lymphocytes ; Dendritic Cells ; HIV Core Protein p24/metabolism ; Lymphoid Tissue ; Mice ; Poly I-C/pharmacology

المؤلفون: Garcia-Beltran WF; Department of Pathology, Massachusetts General Hospital, Boston, MA, United States., Claiborne DT; Ragon Institute of MGH, MIT and Harvard, Massachusetts General Hospital, Cambridge, MA, United States., Maldini CR; Ragon Institute of MGH, MIT and Harvard, Massachusetts General Hospital, Cambridge, MA, United States., Phelps M; Ragon Institute of MGH, MIT and Harvard, Massachusetts General Hospital, Cambridge, MA, United States., Vrbanac V; Human Immune System Mouse Program, Ragon Institute of MGH, MIT, and Harvard, Cambridge, MA, United States., Karpel ME; Ragon Institute of MGH, MIT and Harvard, Massachusetts General Hospital, Cambridge, MA, United States.; Division of Medical Sciences, Harvard University, Boston, MA, United States., Krupp KL; Ragon Institute of MGH, MIT and Harvard, Massachusetts General Hospital, Cambridge, MA, United States., Power KA; Ragon Institute of MGH, MIT and Harvard, Massachusetts General Hospital, Cambridge, MA, United States., Boutwell CL; Ragon Institute of MGH, MIT and Harvard, Massachusetts General Hospital, Cambridge, MA, United States., Balazs AB; Ragon Institute of MGH, MIT and Harvard, Massachusetts General Hospital, Cambridge, MA, United States., Tager AM; Center for Immunology and Inflammatory Diseases, Massachusetts General Hospital, Boston, MA, United States., Altfeld M; Leibniz Institute for Experimental Virology, Hamburg, Germany., Allen TM; Ragon Institute of MGH, MIT and Harvard, Massachusetts General Hospital, Cambridge, MA, United States.

المصدر: Frontiers in immunology [Front Immunol] 2021 May 26; Vol. 12, pp. 667393. Date of Electronic Publication: 2021 May 26 (Print Publication: 2021).

نوع المنشور: Journal Article; Research Support, N.I.H., Extramural; Research Support, Non-U.S. Gov't

بيانات الدورية: Publisher: Frontiers Research Foundation] Country of Publication: Switzerland NLM ID: 101560960 Publication Model: eCollection Cited Medium: Internet ISSN: 1664-3224 (Electronic) Linking ISSN: 16643224 NLM ISO Abbreviation: Front Immunol Subsets: MEDLINE

مواضيع طبية MeSH: Immune Reconstitution*, HIV Infections/*immunology , HIV Infections/*virology , HIV-1/*immunology, Animals ; Biological Evolution ; CD4-Positive T-Lymphocytes/immunology ; CD8-Positive T-Lymphocytes/immunology ; Disease Models, Animal ; HIV Infections/metabolism ; Humans ; Mice ; Mice, Inbred NOD ; Mice, SCID ; Viremia